Why Are Some People Against GLP-1s? A Doctor's Honest Take

GLP-1 medications are everywhere right now, and so is the pushback against them. Some of that criticism is thoughtful, some of it is noise, and as a physician I think it is worth engaging honestly rather than waving away. If you are considering one of these medications, or already taking one, understanding the objections will help you think clearly, and maybe field a few opinions from people in your life along the way.

I am Dr. Jennifer Mbianda. I am triple board-certified in family medicine, obesity medicine, and aesthetics. Here are the real reasons people push back, and my honest take on each.

"It feels like a shortcut"

This is the objection underneath a lot of the others: a sense that using medication to lose weight is somehow cheating, or avoiding hard work. I understand where it comes from, but I do not agree with it, and here is why.

We do not tell people with high blood pressure that medication is cheating. We do not say it about cholesterol, diabetes, or depression. Obesity is a medical condition influenced by genetics, hormones, and metabolism, not simply a failure of willpower. Using an effective tool to treat it is not a moral shortcut. And in practice, the people I see do the medication and the work, since the habits around protein, movement, and nutrition matter just as much on the medication as off it. The tool does not replace the effort. It makes the effort possible for people it was not working for before.

"We do not know the long-term effects"

This is the most reasonable objection on the list, and I will not pretend otherwise. These medications are newer in the weight-management space, and while the underlying drug class has been used in diabetes care for many years, our longest-term data in this specific context is still accumulating.

My honest take is that this is a fair reason for thoughtfulness, not fear. It is exactly why proper screening and consistent follow-up with a prescriber matter so much. It is also worth weighing against the well-established risks of untreated obesity, which are not hypothetical. There is no risk-free option here, only a real comparison to make with your doctor.

"It is too expensive, and access is unfair"

This one is not really about the medicine, and it is a legitimate frustration. These medications can be costly, insurance coverage is inconsistent, and that creates genuine inequality in who can access them. I do not have a tidy answer for it. It is a real problem in our healthcare system, and it is fair to be bothered by it. It is worth separating, though, from the question of whether the medication works or is safe, which is a different issue.

"People will regain the weight when they stop"

There is truth underneath this one. For many people, appetite returns when the medication stops, and without preparation, some regain can follow. But I do not read that as an argument against the medication. I read it as an argument for treating it seriously, building strong habits alongside it, and planning the transition off with your doctor rather than winging it. We do not consider a medication a failure because stopping it changes things. We plan for that.

"It is being overprescribed and overhyped"

I have some sympathy here. The cultural frenzy around these medications has gotten ahead of the careful, individualized medicine they deserve. When something is this popular, it is easy for the screening and follow-up to get rushed, and that is a real concern. But the answer to overhype is not avoidance. It is good medicine: careful candidacy conversations, honest expectations, and proper follow-up. The frenzy is a reason to be more careful, not a reason to write the tool off.

Where I land

My honest take, after all of it, is that the strongest objections are really arguments for using these medications thoughtfully, not arguments against them existing. The shortcut framing does not hold up against how we treat every other chronic condition. The long-term-data concern is real and is best answered with careful medicine. The cost issue is legitimate and separate. And the regain worry is a planning problem, not a verdict.

If you are skeptical, that is not a bad instinct. Skepticism, pointed in the right direction, makes you a better-informed patient. Bring the hard questions to your doctor. A good one will welcome them.

The bottom line

The pushback against GLP-1s is a mix of fair points and cultural noise. The medication is not a moral shortcut, the long-term-data concern is real and manageable with good care, the cost problem is legitimate, and the regain worry is a reason to plan rather than a reason to avoid. Understanding the objections does not mean the medication is wrong for you or right for you. It means you can decide with clear eyes, which is exactly where you want to be.

This content is for general educational purposes and is not medical advice. Talk to your doctor about whether a GLP-1 medication is right for your individual situation.